[33996-58-6] Etiracetam AKSci R856
 
 
Loading Please Wait...
  Catalog ID # R856
Etiracetam
, 98% (HPLC)
 
Levetiracetam Racemic Mixture




IDENTITY
CAS Number:[33996-58-6]
MDL Number:MFCD00868507
MF:C8H14N2O2
MW:170.21
SPECIFICATIONS & PROPERTIES
Purity:98% (HPLC)
Available Spectra:NMR, LCMS, FT-IR, HPLC, Polarimetry
Physical Form:White to off-white crystals
Melting Point:118-124°C
Long-Term Storage:Store at room temperature
UN #:UN3077
Hazard Class:9
Packing Group:III

REVIEW

 Etiracetam is an orally-administered racemic nootropic and antiepilieptic drug of the racetam family. its biologically active enantiomeric form is levetiracetam, the S-enantiomer, which is considerably more active than its R-enantiomer, UCB L-060. Etiracetam is a muscarinic acetylcholine receptor (mAChR) agonist and synaptic vesicle glycoprotein 2A modulator. Use of this compound has been replaced by use of levetiracetam, the S-enantiomer.

REFERENCES
[1]Strubbe, Joseph H. L.; Linz, Raymond A Pharmaceutical (2-oxopyrrolidine)acetamide derivatives Ger. Offen. (1971), DE 2106418 A 19710819.
[2] Pharmacologically active N-substituted lactams Belg. (1971), BE 762728 A4 19710810.
[3] Strubbe, Joseph 2-Pyrrolidone derivatives for the treatment of vascular diseases in humans Ger. Offen. (1978), DE 2746761 A1 19780420.
[4] Sara S J Memory retrieval deficits: alleviation by etiracetam, a nootropic drug Psychopharmacology (1980), 68(3), 235-41.
[5] Wolthuis O L Behavioural effects of etiracetam in rats Pharmacology, biochemistry, and behavior (1981), 15(2), 247-55.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H302; H319; H411

Precautionary Statements
P273; P305+P351+P338


RELATED PRODUCTS
G626Levetiracetam
R856Etiracetam
5018AFLevetiracetam impurity A

Current as of December 3, 2016


Download SDS

CATEGORIES

 APIs and Bioactives > Anticonvulsants

USEFUL LINKS

  PubChem  @PubMed